Blog: VERASTEM, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K) – marketscreener.com

Item 7.01. Regulation FD Disclosure

On January 11, 2022, Verastem, Inc. posted its corporate presentation on its
website, a copy of which is furnished hereto as Exhibit 99.1.


Item 8.01. Other Events


On January 11, 2022, Verastem, Inc. issued a press release outlining key 2022
strategic priorities and upcoming catalysts for advancing VS-6766 as a backbone
of therapy for RAS pathway-driven cancers. A copy of the press release is filed
hereto as Exhibit 99.2.

Item 9.01. Financial Statements and Exhibits



Exhibit No.                                Description
99.1             Corporate Presentation, dated January 11, 2022
99.2             Press Release, dated January 11, 2022
104            Cover Page Interactive Data File (formatted in Inline XBRL and
               contained in Exhibit 101)

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s